Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-04 Sale | 2024-12-05 4:15 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 3,620 | $0.81 | $2,932 | 1,128,312 (Direct) | View |
| 2024-11-05 Sale | 2024-11-06 4:06 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 3,675 | $0.9106 | $3,346 | 1,131,932 (Direct) | View |
| 2024-10-04 Sale | 2024-10-07 4:44 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 3,607 | $0.8793 | $3,172 | 1,135,607 (Direct) | View |
| 2024-09-04 Sale | 2024-09-05 4:28 pm | Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary | 3,971 | $0.7218 | $2,866 | 273,881 (Direct) | View |
| 2024-09-04 Sale | 2024-09-05 4:26 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 3,667 | $0.7218 | $2,647 | 1,139,214 (Direct) | View |
| 2024-09-04 Sale | 2024-09-05 4:24 pm | Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer | 7,050 | $0.7218 | $5,089 | 391,054 (Direct) | View |
| 2024-09-04 Sale | 2024-09-05 4:13 pm | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 5,356 | $0.7218 | $3,866 | 404,051 (Direct) | View |
| 2024-08-06 Sale | 2024-08-08 4:31 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 3,608 | $0.9299 | $3,355 | 1,142,881 (Direct) | View |
| 2024-07-30 Sale | 2024-07-31 4:14 pm | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 2,883 | $1.06 | $3,056 | 326,628 (Direct) | View |
| 2024-07-05 Sale | 2024-07-09 4:15 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 3,616 | $0.851 | $3,077 | 1,146,489 (Direct) | View |
| 2024-06-05 Sale | 2024-06-07 7:18 pm | Karyopharm Therapeutics Inc. | KPTI | PAKIANATHAN DEEPIKA Director | 818,044 | $0.95964 | $785,027 | 0 (Indirect) | View |
| 2024-06-04 Sale | 2024-06-06 4:03 pm | Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer | 652 | $0.99 | $645 | 398,104 (Direct) | View |
| 2024-06-04 Sale | 2024-06-06 4:02 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 3,592 | $0.99 | $3,556 | 1,150,105 (Direct) | View |
| 2024-05-31 Sale | 2024-06-04 6:51 pm | Karyopharm Therapeutics Inc. | KPTI | PAKIANATHAN DEEPIKA Director | 906,178 | $0.97188 | $880,693 | 7,911 (Indirect) | View |
| 2024-05-06 Sale | 2024-05-07 4:56 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 3,576 | $1.13 | $4,041 | 1,153,697 (Direct) | View |
| 2024-04-22 Sale | 2024-04-23 4:02 pm | Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer | 6,789 | $1.17 | $7,943 | 342,931 (Direct) | View |
| 2024-04-04 Sale | 2024-04-05 5:20 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 3,563 | $1.29 | $4,596 | 1,157,273 (Direct) | View |
| 2024-03-05 Sale | 2024-03-06 4:14 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 3,573 | $1.3 | $4,645 | 1,160,836 (Direct) | View |
| 2024-02-29 Sale | 2024-03-04 7:41 pm | Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer | 21,636 | $1.1783 | $25,493 | 349,720 (Direct) | View |
| 2024-02-29 Sale | 2024-03-04 7:40 pm | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 22,466 | $1.1782 | $26,470 | 329,511 (Direct) | View |
| 2024-02-29 Sale | 2024-03-04 7:39 pm | Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer | 33,849 | $1.1755 | $39,788 | 398,756 (Direct) | View |
| 2024-02-29 Sale | 2024-03-04 7:38 pm | Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary | 20,549 | $1.1752 | $24,150 | 277,852 (Direct) | View |
| 2024-02-29 Sale | 2024-03-04 7:37 pm | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 26,949 | $1.1757 | $31,684 | 393,509 (Direct) | View |
| 2024-02-29 Sale | 2024-03-04 7:36 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 99,844 | $1.1758 | $117,399 | 1,164,409 (Direct) | View |
| 2024-02-27 Sale | 2024-02-29 5:35 pm | Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer | 2,545 | $1.3238 | $3,369 | 432,605 (Direct) | View |
| 2024-02-15 Sale | 2024-02-20 4:59 pm | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 5,847 | $1.3312 | $7,783 | 163,772 (Direct) | View |
| 2024-02-06 Sale | 2024-02-08 4:36 pm | Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer | 4,205 | $1.5865 | $6,671 | 246,945 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-11-22 4:01 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 0 | $0 | 140,300 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-30 5:32 pm | N/A 2034-05-28 | Karyopharm Therapeutics Inc. | KPTI | Su Zhen Director | 50,587 | $0 | 50,587 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-30 5:32 pm | N/A 2034-05-28 | Karyopharm Therapeutics Inc. | KPTI | Schor Chen Director | 69,000 | $0 | 69,000 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-30 5:32 pm | N/A 2034-05-28 | Karyopharm Therapeutics Inc. | KPTI | PAKIANATHAN DEEPIKA Director | 69,000 | $0 | 69,000 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-30 5:32 pm | N/A 2034-05-28 | Karyopharm Therapeutics Inc. | KPTI | Oliger Christy J. Director | 69,000 | $0 | 69,000 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-30 5:32 pm | N/A 2034-05-28 | Karyopharm Therapeutics Inc. | KPTI | Mirza Mansoor Raza Director | 69,000 | $0 | 69,000 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-30 5:25 pm | N/A 2034-05-28 | Karyopharm Therapeutics Inc. | KPTI | Greene Barry E Director | 69,000 | $0 | 69,000 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-30 5:19 pm | N/A 2034-05-28 | Karyopharm Therapeutics Inc. | KPTI | BOHLIN GAREN G Director | 69,000 | $0 | 69,000 (Direct) | View |
| 2024-02-28 Option Award | 2024-02-29 5:36 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer | 198,959 | $0 | 371,356 (Direct) | View |
| 2024-02-28 Option Award | 2024-02-29 5:35 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 188,205 | $0 | 351,977 (Direct) | View |
| 2024-02-28 Option Award | 2024-02-29 5:35 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer | 188,205 | $0 | 432,605 (Direct) | View |
| 2024-02-28 Option Award | 2024-02-29 5:35 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary | 147,000 | $0 | 298,401 (Direct) | View |
| 2024-02-28 Option Award | 2024-02-29 5:35 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 198,959 | $0 | 420,458 (Direct) | View |
| 2024-02-28 Option Award | 2024-02-29 5:34 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 442,800 | $0 | 1,264,253 (Direct) | View |